LAUSR

Turmeric root is an ancient Ayurvedic herb, and it is used as a spice, and in very low doses, it may modulate immune-inflammatory diseases of the gut, joints, brain, and body in turmeric-consuming part of the world. Turmeric contains more than 235 active ingredients including essential oils, curcuminoids (>89), and turmerosaccharides as well as curcuminoid-free ingredients and fiber. These phytochemicals and fiber as well as their metabolites and products of microbial degradation may act in additive or synergistic fashion as a modulator of persistent dysregulated chronic immune inflammation and pain in horses, pets, and people. The limited preclinical data support that low doses of turmeric or its active ingredient (curcumin/curcuminoids) may have modulatory applications in preventing or treating immuneinflammatory diseases of the eyes, brain, joints, and gut in pets and people. The standardized turmeric (ST) is a novel concept; it is based on a recently filled patent. ST may reduce the need for analgesics (opiates), antidepressants, steroids, and anticancer medications. Using the latest drug-targeted delivery and reliable clinical trial strategies, ST may be considered for R&D for the prevention and treatment of OA, dementia, and other age-related diseases of the eyes, brain, gut, and joints in pets and humans. The consumers need to be aware of the adulterations of turmeric and its extracts.